Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow
- PMID: 19388812
- DOI: 10.1089/scd.2008.0375
Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow
Abstract
We have shown that bone marrow (BM) from untreated advanced lung and breast cancer patients (LCP and BCP) have a reduced number of colony-forming unit fibroblasts (CFU-Fs) or mesenchymal stem cells (MSCs). Factors that regulate the proliferation and differentiation of CFU-F are produced by the patients' BM microenvironment. We have now examined whether conditioned media (CM) from patients' CFU-F-derived stromal cells also inhibits the colony-forming efficiency (CFE) of CFU-F in primary cultures from healthy volunteers (HV)-BM. Thus the number and proliferation potential of HV-CFU-F were also found to be decreased and similar to colony numbers and colony size of patients' CFU-F. Stromal cells from both of these types of colonies appeared relatively larger and lacked the characteristic spindle morphology typically seen in healthy stromal cells. We developed an arbitrary mesenchymal stromal cell maturational index by taking three measures consisting of stromal cell surface area, longitudinal and horizontal axis. All stromal indices derived from HV-CFU-F grown in patients' CM were similar to those from stromal elements derived from patients' CFU-F. These indices were markedly higher than stromal indices typical of HV-CFU-F cultured in healthy CM or standard medium [alpha-medium plus 20% heat-inactivated fetal bovine serum (FBS)]. Patients' CM had increased concentrations of the CFU-F inhibitor, GM-CSF, and low levels of bFGF and Dkk-1, strong promoters of self-renewal of MSCs, compared to the levels quantified in CM from HV-CFU-F. Moreover, the majority of patients' MSCs were unresponsive in standard medium and healthy CM to give CFU-F, indicating that the majority of mesenchymal stromal cells from patients' CFU-F are locked in maturational arrest. These results show that alterations of GM-CSF, bFGF, and Dkk-1 are associated with deficient cloning and maturation arrest of CFU-F. Defective autocrine and paracrine mechanisms may be involved in the BM microenvironments of LCP and BCP.
Similar articles
-
Alteration on the expression of IL-1, PDGF, TGF-beta, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients.Stem Cells Dev. 2005 Oct;14(5):587-94. doi: 10.1089/scd.2005.14.587. Stem Cells Dev. 2005. PMID: 16305343
-
Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells.J Cell Physiol. 2007 Sep;212(3):817-26. doi: 10.1002/jcp.21080. J Cell Physiol. 2007. PMID: 17458904
-
Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients.Ann Hematol. 2002 Feb;81(2):80-5. doi: 10.1007/s00277-001-0410-y. Epub 2002 Jan 18. Ann Hematol. 2002. PMID: 11907787
-
Marrow stromal stem cells.J Cell Sci Suppl. 1988;10:63-76. doi: 10.1242/jcs.1988.supplement_10.5. J Cell Sci Suppl. 1988. PMID: 3077943 Review.
-
The bone marrow niche in support of breast cancer dormancy.Cancer Lett. 2016 Sep 28;380(1):263-71. doi: 10.1016/j.canlet.2015.10.033. Epub 2015 Nov 3. Cancer Lett. 2016. PMID: 26546045 Review.
Cited by
-
Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy.Front Bioeng Biotechnol. 2022 Apr 14;10:882545. doi: 10.3389/fbioe.2022.882545. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35497332 Free PMC article. Review.
-
In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis.Biol Res. 2012;45(3):279-87. doi: 10.4067/S0716-97602012000300009. Biol Res. 2012. PMID: 23283437 Free PMC article. Review.
-
Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.J Clin Invest. 2011 Aug;121(8):3206-19. doi: 10.1172/JCI45273. J Clin Invest. 2011. PMID: 21737876 Free PMC article.
-
Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients.Oncol Res. 2023 May 24;31(3):361-374. doi: 10.32604/or.2023.028104. eCollection 2023. Oncol Res. 2023. PMID: 37305388 Free PMC article.
-
GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.Cancer Discov. 2016 Aug;6(8):886-99. doi: 10.1158/2159-8290.CD-15-0947. Epub 2016 May 16. Cancer Discov. 2016. PMID: 27184426 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical